A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral ...
Treatment for short bowel syndrome varies by stage and may include intravenous (IV) nutrition, feeding tubes, dietary changes ...
Hosted on MSN
Living well with inflammatory bowel disease
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, affects millions and can be life-altering. Beyond medications, research highlights the role of gut microbiome health ...
An intestinal pathogen reshapes the gut environment to fuel its own colonization and cause diseases, a multi-institutional ...
A stem cell-derived intestine model reveals glycyrrhizin as a potential treatment for inflammatory bowel disease.
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized ...
The terms "intestinal barrier" and "intestinal permeability" describe two different aspects of the same anatomical structure, the intestinal wall composed of four layers, the mucosa, the submucosa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results